Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

7072  relevant articles (695 outcomes, 1216 trials/studies) found for this Bio-Agent

ACE Inhibitors; Angiotensin I-Converting Enzyme Inhibitors; Angiotensin-Converting Enzyme Antagonists; Antagonists, Angiotensin-Converting Enzyme; Antagonists, Kininase II; Inhibitors, ACE; Inhibitors, Angiotensin-Converting Enzyme; Inhibitors, Kininase II; Kininase II Antagonists; Angiotensin Converting Enzyme Antagonists; Angiotensin Converting Enzyme Inhibitors; Angiotensin I Converting Enzyme Inhibitors; Antagonists, Angiotensin Converting Enzyme; Enzyme Antagonists, Angiotensin-Converting; Enzyme Inhibitors, Angiotensin-Converting; Inhibitors, Angiotensin Converting Enzyme; Kininase II Inhibitors

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Ahmed, Ali: 11 articles (09/2006 - 07/2002)
2.	Yusuf, Salim: 7 articles (09/2006 - 01/2002)
3.	Torp-Pedersen, Christian: 6 articles (02/2008 - 08/2004)
4.	van Veldhuisen, Dirk J: 5 articles (08/2008 - 03/2005)
5.	Pilote, Louise: 5 articles (05/2008 - 10/2003)
6.	Aronow, Wilbert S: 5 articles (02/2008 - 05/2002)
7.	Maggioni, Aldo P: 5 articles (02/2008 - 10/2002)
8.	Swedberg, Karl: 5 articles (08/2005 - 09/2003)
9.	Køber, Lars: 4 articles (02/2008 - 04/2005)
10.	Cohn, Jay N: 4 articles (01/2007 - 10/2002)

Related Diseases

1.	Heart Failure 11/01/2000 - "Although most primary care physicians stated they prescribe ACE inhibitors in heart failure, this was for only 47-62% of patients, and at doses below those identified as effective in trials. " 10/02/1990 - "An understanding of the renal effects of ACE inhibitors permits their safe and effective use in most patients with congestive heart failure." 02/01/2000 - "BACKGROUND: Although angiotensin-converting enzyme inhibitors are recommended as first line therapy in patients with chronic heart failure, the target doses proven to be effective in major morbidity and mortality trials (e.g. " 12/01/1997 - "BACKGROUND: Several studies document an underuse of angiotensin-converting enzyme inhibitors (ACEIs) in heart failure (HF) patients, despite their proven efficacy and good tolerability. " 12/01/2002 - "Given the dramatic decline in quality of life with heart failure, this end-point should be a much more important target for healthcare interventions, especially treatments such as ACE inhibitors and beta-blockers that are shown to improve quality of life." Order ALL the reference details at left...
2.	Hypertension (High Blood Pressure) 03/01/2000 - "Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?" 09/01/2006 - "Angiotensin-converting enzyme inhibitors have been shown to provide excellent organ protection in hypertension, and may show dose-dependent protective effects. " 08/01/2001 - "Inasmuch as AT1 receptor antagonists have proven themselves the equals of angiotensin converting enzyme inhibitors with respect to antihypertensive efficacy, but demonstrated better safety profiles, this class of drugs may be considered to be a qualitative improvement in the treatment of essential hypertension. " 04/01/1990 - "The ACE inhibitors are assuming a dominant role in our therapeutic armamentarium, in that they are well-tolerated and very effective in the treatment of mild, moderate or severe hypertension." 11/01/2006 - "Interventional studies have shown that partial correction of anaemia through epoetin, together with an arterial hypertension successful therapy through renin-angiotensin system acting drugs, such as ACE-inhibitors, were able to induce a LVH regression in CKD. " Order ALL the reference details at left...
3.	Myocardial Infarction 08/01/1996 - "Most clinical trials of angiotensin converting enzyme inhibitors after myocardial infarction have shown an improved outcome with reduction of morbidity and mortality. " 06/01/2000 - "BACKGROUND: ACE inhibitors have shown beneficial results in several studies after myocardial infarction (MI). " 03/01/2000 - "The results of major clinical trials leave us in no doubt that ACE inhibitors are useful in the treatment of patients after myocardial infarction. " 07/06/1998 - "The SAVE trial specifically evaluated the effects on post-myocardial infarction mortality and remodeling and found that ACE inhibitors were effective in reducing both. " 01/01/2008 - "Angiotensin Converting Enzyme inhibitors (ACE-I) are effective in reducing mortality and preventing left ventricular (LV) function deterioration after myocardial infarction. " Order ALL the reference details at left...
4.	Proteinuria 04/01/1992 - "Patients with recurrent FGS who were treated with ACE inhibitors benefited from a significant reduction of proteinuria. " 01/01/2008 - "Reduction in proteinuria from ARBs and ACE inhibitors is similar, but their combination is more effective than either drug alone. " 05/22/1995 - "RESULTS: In 14 randomized controlled trials, angiotensin-converting enzyme inhibitors caused a greater decrease in proteinuria (pooled mean [95% confidence intervals], -0.51[-0.68 to -0.35], ln [treatment/control]), improvement in glomerular filtration rate (0.13 mL/min per month [0.10 to 0.16 mL/min per month]), and decline in mean arterial pressure (-4.0 mm Hg [-4.9 to -3.0 mm Hg]) compared with controls. " 09/01/2007 - "As it has been demonstrated that angiotensin-converting enzyme inhibitors (ACEi) have a renoprotective effect in adults with proteinuric disease and may be effective in reducing hyperfiltration and proteinuria, they are also frequently used as anti-progression agents in paediatric patients with CKD despite the lack of data confirming their role in the nephropathies peculiar to children. " 03/01/2007 - "ACE inhibitors are effective in controlling proteinuria in patients with microalbuminuria y proteinuria. " Order ALL the reference details at left...
5.	Diabetic Nephropathies (Diabetic Nephropathy) 01/01/1993 - "Strict glycemic control, and ACE inhibitors may be beneficial in early stages of diabetic nephropathy. " 01/01/2005 - "CONCLUSION: As in other causes of non-diabetic kidney disease, antihypertensive regimens with ACE inhibitors are more effective in lowering urine protein excretion in patients with advanced PKD compared to regimens without ACE inhibitors, and this benefit is greater in patients with higher levels of baseline urine protein excretion. " 01/01/2003 - "OBJECTIVE: ACE inhibitors are known to be effective in preventing the progression of diabetic nephropathy. " 07/01/2001 - "The two main treatment strategies for primary prevention of diabetic nephropathy are improved glycaemic control and blood pressure lowering, particularly using drugs such as angiotensin-converting enzyme inhibitors. " 09/01/1989 - "The relative superiority of ACE inhibitors in slowing the progression of chronic parenchymal renal disease remains to be demonstrated, although promising results have been reported in patients with diabetic nephropathy." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
2.	Angiotensins
3.	Diuretics
4.	Angiotensin Receptors (Angiotensin II Receptor)
5.	Calcium
6.	Calcium Channel Blockers (Blockers, Calcium Channel)
7.	Angiotensin II
8.	Digoxin (Digitek)
9.	Captopril (Capoten)
10.	Antihypertensive Agents (Antihypertensives)

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Drug Therapy (Chemotherapy)
3.	Transplantation (Transplant Recipients)
4.	Highly Active Antiretroviral Therapy (HAART)
5.	Kidney Transplantation